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         Preface 
 
Between 1980 and roughly 1996, about 750,000 cattle infected with BSE 
(bovine spongiform encephalopathy) were slaughtered for human consumption 
in Great Britain, and it is now clear that BSE, also known as “mad cow disease” 
is not merely a UK phenomenon, nor is it merely an economic nuisance. The 
sudden and explosive increase of BSE in recent Europe (1990-2000) may have 
been spread among cattle by the feeding of infected offal, but the majority of 
cases of naturally occurring prion diseases arise sporadically with no known 
cause.  Thus, the most important problem to be solved is to elucidate the 
intrinsic chemical mechanism of the prion diseases which arise sporadically, 
i.e., we must answer the questions: 
 
What induces the conversion of normal prion protein into an 
abnormal isoform, and how the abnormal isofom forms without the 
infected offals ? 
 
Many years ago ALS (amyotrophic lateral sclerosis) patients were 
collectively found in the New Guinea and Papua islands, and its origin has been 
attributed to the subterranean water, which contains much Al3+ and Mn2+ ions. In 
Alzheimer’s disease specific region such as the hippocampus and the motor 
cortex contain elevated iron levels relative to normal, and abnormalities in brain 
iron metabolism have been described for several neurodegenerative disorders, 
including Alzheimer’s diseases, Parkinson’s disease, Huntington’s, and prion 
diseases. Investigations of scrapie, CJD, and chronic wasting disease clusters in 
Iceland, Slovakia and Colorado, respectively have indicated that the soil in these 
regions is low in copper and higher in manganese.  
 
Above facts suggest that the sporadic prion and other neurodegenerative 
diseases are closely related with the function of several transition-metal ions, and 
thus inorganic-biochemical perspectives are necessary in order to elucidate the 
chemical mechanisms of pathogenesis of these diseases.  
 
 
October 20th, 2006 
                                       Yuzo Nishida 
     Chemical Institute for Neurodegeneration, Yamagata University
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                Chapter I.  Introduction  
 
Between 1980 and roughly 1996, about 750,000 cattle infected with BSE 
(bovine spongiform encephalopathy) were slaughtered for human consumption in 
Great Britain, and it is now clear that BSE, also known as “mad cow disease” is 
not merely a UK phenomenon, nor is it merely an economic nuisance. In fact, it 
may be an impending world-wide health crisis, and in recent months several other 
European countries have found BSE in their cattle herds, and over the past few 
years about 100 mostly young individuals have fallen victim to a fatal condition 
known as new variant Creutzfeld-Jacob disease (vJCD). [1-3]  BSE and vJCD 
are one of the transmissible spongiform encephalopathies (TSEs, or prion 
disease) which are group of fatal neurodegenerative disorders that include BSE, 
vJCD, scrapie of sheep, chronic wasting diseases (CWD) of mule deer and elk, as 
well as Gestmann-Straussler-Scheinker disease (GSS) and fatal familial insomnia 
(FFI) of humans. [4,5]  At present it is generally recognized that BSE may have 
originated from a scrapie agent infecting small ruminants, which have been 
recycled through cattle and disseminated through the use of contaminated meat 
and bonemeal. Compelling evidence links vCJD to exposure to beef infected with 
BSE prions, and recent studies have suggested that blood-borne transmission of 
CJD is highly possible.  
     Some 250 years ago, a sheep disease that presented with excitability, 
itching, ataxia and finally paralysis and death was recognized and this is known 
today as scrapie in English-speaking countries, “the trembles” in France, “trotting 
disease” in Germany and “itching disease” in Japan, reflecting the gamut of its 
symptoms.  The first major advance in scrapie research took place in 1936 when 
Cuille and Chelle succeeded in transmitting the disease to sheep and goats by 
inoculating them with lumbar cord of diseased animals.  Subsequently, 
transmission to mice and hamsters provided more-convenient experimental 
models.  It was soon recognized that the transmissible agent had quite 
extraordinary properties, such as unusually long incubation periods, measured in 
months to years, and uncommon resistance to high temperature, formaldehyde 
treatment and UV irradiation.  Enriching fractions from Syrian hamster (SHa) 
brain for scrapie infectivity led to the discovery of the prion protein (PrP), and at 
present it is generally accepted that the central event in TSEs is the 
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post-translational conversion of the normal cellular prion protein (PrPC) into an 
abnormal isoform of called scrapie PrP (PrPSc) that has a high-b-sheet content 
and is associated with transmissible disease. (see Figure 1) [6]  These misfodled 
prions (PrPSc) ultimately kills neurons and leaves the brain riddled with holes, like 
a sponge, and the 1997 Nobel Prize in Physiology and Medicine was awarded to 
Professor S. Prusiner of the University of California, San Francisco, for his 
contributions towards the identification of the infectious agent that causes TSEs. 
    PrPC is a glycoprotein expressed on the surface of many cell types (see 
Figure 2) and the fact that the protein is expressed in neurons at higher levels than 
in any other cell types suggests that PrPC has special importance for neurons.  
Additionally, PrPC is highly concentrated at the synapse and there is evidence for 
intense localization not only as central nerves synapse but also at endplates. PrPC 
is linked to the cell membrane by glycosylphosphatidylinositol (GPI) anchor. (see 
Fig. 2) [7]  It has one or two sugar chains that are closely linked to the 
C-terminus and also exists in a non-glycosylated form.  PrPSc is extracted from 
affected brains as highly aggregated, detergent-insoluble materials that is not 
amenable to high-resolution 
 structural technique. PrPSc is 
 covalently indistinguishable  
from PrPC. During infection,  
theunderlying molecular events  
that lead to the conversion of  
PrPC to the scrapie agent remain  
ill defined. 
     
 
 
Figure 1.  Plausible models for the tertiary structures of PrPSc and PrPC.   
(a) The proposed three-dimensional structure of PrPC.   
It has been believed that helices 1 and 2 are converted  
into a b-sheet structure during the formation of PrPSc.  
(b) The proposed three-dimensionalstructure of PrPSc.  
(S. B. Prusiner, Trends Biochemical Sciences, 1996, 21, 482)  
(a) (b) 
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Figure 2.  Model of PrPC structural domains.   
The folded C-terminal portion of PrPC that contains the short 
b-sheet strands and the a-helix is based on a model derived from 
NMR-based coordinates of residues of hamster PrP. (B. Caughey, 
Trends Biochemical Sciences, 2001, 25, 235) 
 
 
Recent studies have showed that PrPC not only binds copper (Cu) within the 
octarepeat region located in the unstructured N-terminus, but under certain 
specific circumstances may bind along the C-terminal structured domain of 
protein fragments. Furthermore, recombinant PrPC can also bind other metals 
such as manganese at both the octarepeats and the C-terminal sites. [8]  Indeed, 
accumulating evidence suggests that metallochemical alterations may play a role 
in the pathogenesis of prion diseases and other neurodegenerative diseases.  It 
has been demonstrated that both recombinant and brain-derived PrP have 
superoxide dismutase (SOD)-like activity when Cu is bound to the octarepeat 
region resulting in conformational changes to the protein. [8]  
 
The sudden and explosive increase of BSE in recent Europe may have 
been spread among cattle by the feeding of infected offal [9-12] but the majority 
of cases of naturally occurring prion diseases arise sporadically with no known 
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cause.  Thus, the most important problem to be solved is to elucidate the 
intrinsic chemical mechanism of the prion diseases which arise sporadically, 
i.e., we must answer the questions: 
 
What induces the conversion of PrPC to PrPSc and how the PrPSc 
forms in the life process without the infected offals ? 
 
The sporadic neurodegenerative diseases are in general endemic; many years 
ago ALS (amyotrophic lateral sclerosis) patients were collectively found in the 
New Guinea and Papua islands, and its origin has been attributed to the drinking 
subterranean water, which contains much Al3+ and Mn2+ ions, and in these 
regions many patients of Alzheimer’s and Parkinson’s diseases were found, [13] 
and increased aluminum levels were reported in the hippocampus of patients with 
Alzheimer’s disease. [14]  In Alzheimer’s disease specific region such as the 
hippocampus and the motor cortex contain elevated iron levels relative to normal, 
whereas the occipital cortex contains decreased levels, and abnormalities in brain 
iron metabolism have been described for several neurodegenerative disorders, 
including Alzheimer’s diseases, Parkinson’s disease, Huntington’s, and prion 
diseases. [14-17] Investigations of scrapie, CJD, and chronic wasting disease 
clusters in Iceland, Slovakia and Colorado, respectively have indicated that the 
soil in these regions is low in copper and higher in manganese, and Brown et al. 
observed striking elevation of manganese ion accompanied by significant 
reduction of copper ion bound to purified PrP in all sCJD (sCJD = sporadic CJD) 
variants. [18] Brown et al. have reported that it loses the SOD-like activity when 
Cu is replaced with Mn in recombinant PrP, and also that Cu binding to PrP 
purified from sporadic CJD was significantly decreased while the binding of Mn 
and Zn was markedly increased. [18]  These results suggest that altered 
metal-ion occupancy of PrP plays a pivotal role in the pathogenesis of prion 
diseases.  
 
In this book we will show the new concept on the “oxidative stress” 
induced by the metal ions such as copper, manganese, and iron, etc, [19]  to 
lead to the sporadic prion diseases and other neurodegenerative diseases which 
include ALS, Alzheimer’s and Parkinson’s, and will postulate the comprehensive 
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chemical mechanism of the sporadic prion diseases.. 
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Chapter II  Parkinson’s Disease: Deficiency of 
 Neurotransmitters and Neural Cell Death  
due to Oxidative stress 
 
In October 2000, the Nobel Assembly awarded the Nobel Prize in 
Physiology and Medicine to Carlsson of the University of Gothernburg in 
Sweden and to two pioneers in the study of nerve cell communications; Paul 
Greengard of Rockefeller University in New York City, who figured out how 
dopamine and other neurotransmitters trigger target neurons when they bind at the 
synapse, the junction between two nerve cells; and Eric Kandel of New York’s 
Columbia University, who built on these insights to demystify some aspects of 
learning and memory.  Carlsson overturned conventional wisdom by proving 
that dopamine, once thought to be merely a precursor in the synthesis of the 
neurotransmitter norepinephrine (see Figure 3), is an important nervous system 
messenger in its own right.  They gave rabbits a drug that depletes 
norepinephrine in the brain, putting the animals into a temporary stupor.  
Carlsson found that the rabbits could be roused with injections of L-dopa, which 
the brain converts to dopamine. Later they discovered that Parkinson’s diseases 
results from degeneration of dopamine-producing neurons in the brain involved 
movement control. That finding led to the use of L-dopa as a therapy for 
Parkinson’s patients. 
 
Greengard et al. have found that in most neurons the neurotransmitters 
exert their effects by triggering a so-called second messenger inside the target 
cells.  This in turn activates an enzyme that adds phosphate groups to cellular 
proteins, setting off a chain of events that alter nerve cell properties.  To date, 
they have identified more than 100 brain proteins phosphorated as a result of 
neurotransmitter activity, including that serves as a kind of master control switch 
for dopamine.  The link between phosphorylation and nerve cell signaling 
inspired the research of Kandel into how the brain learns and remembers.  They 
demonstrated that the responses of Aplysia’s nerve cells to various stimuli were 
amplified according to the strength and duration of the stimuli.   
 
Parkinson’s disease (PD) is a common neurodegenerative disorder that is 
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clinically characterized by tremor, bradykinesia, rigidity, and loss of postural 
reflexes.  It is generally believed that the major symptoms of PD are caused by a 
striatal dopamine (DA) deficiency, secondary to degeneration of nigrostriatal 
dopaminergic neurons and possibly a decreased DA-biosynthetic capacity in the 
surviving cells. [1,2] Although the DA loss is most pronounced, norepinephrine, 
serotonin, and melanin pigments are also decreased, whereas cholinergic activity 
seems to be increased.  The selective loss of specific neurons in the central 
nervous system (CNS) is a characteristic feature for PD and other common 
neurodegenerative disorders, such as Alzheimer’s disease, Huntington’s chorea, 
amyotrophic lateral sclerosis (ALS), and also “mad cow disease”.  Although 
originally discounted, hereditary factors have emerged as the focus of research in 
PD; recent studies suggest that hereditary factors play an important role in 
sporadic PD, and two genes are clearly associated with the diseases; a-synuclein 
and parkin, and as a third, gene ubiquitin C-terminal hydroxylase L1. [3]   
Let us at first consider the biochemical synthesis of dopamine. The 
chemical mechanism of dopamine synthesis has been elucidated by the 
biochemists, and the result is illustrated in Figure 3.  Dopamine is synthesized 
from phenylalanine and tyrosine, one of the 20 essential amino-acids through the 
oxygenation reaction at the benzene ring by the enzymes, phenylalanine 
hydroxylase (PAH) or tyrosine hydroxylase (TH) (see Figure 4).  It should be 
noted here that the oxygenation at the benzene ring does not occur in the air 
without the catalyst, and thus it is necessary for us to know the detail chemical 
mechanism of the enzymes, TH or PAH, and or tryptophan hydroxylase, which 
catalyzes the formation of serotonin from tryptophan; the deficiency of serotonin 
has been proposed to induce several metal diseases, such as  depression etc.   
TH is a non-heme iron protein that uses one molecule of dioxygen to 
hydroxylate its amino acid and tetrahydropterin substrates to hydroxy-amino 
acids and 4a-hydroxytetrahydropterins, respectively. (see Figure 4) [4,5]  As the 
4a-hydroxytetrahydropterins subsequently dehydrates and is regenerated by the 
NADH-dependent enzyme dihydropteridine reductase, it is frequently termed a 
cofactor for the peteridine-dependent hydroxylases.  The cofactor (BH4) is the 
most abundant of the unconjugated tetrahydropterins in mammalian tissues and is 
considered to be the naturally tetrahydropterin substrate for these enzymes.  The 
active site structure and catalytic mechanism of the aromatic amino acid 
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hydroxylases have been investigated by kinetic and spectroscopic techniques, as 
well as by site-directed mutagenesis.  The iron is necessary for catalytic 
turnover, (see chapter V) and the tetrahydropterin and amino acid substrates bind 
close to the iron(II) center, but probably without a direct coordination to the metal 
center. Thus, it is clear that iron-deficiency should lead to deficiency of 
neurotransmitters, such as dopamine, serotonin, etc. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Synthesis scheme of neurotransmitters 
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 Figure 4.  Formation of dopa from tyrosine catalyzed by TH 
 
As indicated in Chapter I, increased brain iron concentrations at some 
special regions have been described in Parkinson’s disease, [1] but these iron ions 
do not contribute to the formation of dopamine; the reason will be developed in 
Chapter VI.  The cause of nigral cell death in the Parkinson’s disease remains 
unsolved, but many authors have pointed out the hypothesis that the cellular 
degeneration observed results from oxidative stress.  [2,6-8]  Oxidative stress 
manifests itself as an increased oxidation of cellular constituents (lipids and 
proteins) and DNA damage.  Lipid peroxidation and protein damage have been 
observed in the SN of PD patients, which suggests that oxidative stress is 
involved in the pathogenesis of this disease. 
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The increased iron ions observed in these Parkinson’s and Alzheimer’s 
disorders has been frequently suggested to play a role in catalyzing the production 
of the so-called oxygen free radicals via the metal dependent reduction of 
hydrogen peroxide.  This reaction, sometimes referred to as the Fenton reaction, 
may involve the reaction of hydrogen peroxide with ferrous ion to produce the 
potentially damaging hydroxyl radical (OH•) (see below), and many authors have 
insisted that this OH• should be a main active oxygen species in the oxidative 
stress,  
 
Fe2+ + H2O2           Fe3+ + OH-  + OH• 
 
but it should be noted that free intracellular ferrous iron concentration have been 
calculated to be very low, below 10-8 M, [9] and nobody has succeeded in 
confirming the OH• formation by the reliable chemical methods.  
 
I would like to show that OH• does not exert the oxidative stress in the 
living cell, and to propose the new concept for oxidative stress in this 
monograph (see chapter III) [10] and also show that deficiency of 
neurotransmitters due to the abnormal iron metabolism in brain leads to the neural 
cell death. 
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Chapter III   Nishida’s Concept on Activation of  
Oxygen Molecule 
 
The electronic configuration of the oxygen atom is 1s22s22p4.  When two 
O atoms combine to form O2, the same orbital types combine if they are of equal 
or approximately equal energy.  Thus, the 1s, 2s, 2px, 2py, and 2pz on one 
oxygen combine with the similar orbitals on the other oxygen to give, in each 
case, two MO’s.  The five AO’s on each atom give rise to ten MO’s in the 
molecule. [1] 
Since the electrons will occupy the orbitals in the order of increasing 
energy, we must arrange our MO’s in an energy sequence so that we can place our 
sixteen electrons properly.  One of the most instructive ways to do this is by 
means of the molecular orbital energy diagram method.  In the oxygen molecule 
we have the combination of both 1s and 2s orbitals to give four s type orbitals, 
[1] two bonding and two antibonding, each of them  
occupied by two electrons.  Because the 1s electrons are not valence electrons, 
we usually pay little heed to them.  The combination of the 2s orbitals does not 
result in any net bonding. (see Figure 5)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  MO scheme for O2. 
 
2s 2s
2p
2p
sg(2pz)
su*(2pz)
pu(2px,2py)
pg*(2px,2py)
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The three atomic p orbital levels in the isolated atom are of equal energy 
(degenerate); but when we bring one atom into the field of the other, the pz 
orbitals pointing toward the other atom start to interact to form a s bond between 
the two atoms. the corresponding s* orbital are generated.  These orbitals 
sg(2pz) and su*(2pz), are in fact s molecular orbitals because they are symmetric 
with respect to rotation around the internuclear axis (in this case, z-axis).  The 
bonding interaction is quite large, and hence the splitting is also relatively large. 
(see Figure 5) 
 
The px and py orbitals on each oxygen combine to each from a p set: 
pu(2pu(2px), pg*(2px), pu(2py), pg*(2py).  The px and py orbitals are perpendicular 
to each other.  Now, if we refer to our MO energy diagram, we see that six 
electrons of 2p orbitals are referred to as valence electrons, that is these electrons 
occupy sg(2p) and pu(2p). If we follow the principles used for the periodic 
classification, the two electrons must go separately into the pg*(2px) and pg*(2py) 
orbitals, with spin parallel (Hund’s rule: see Figure 5 and Table 2).  The two 
unpaired electrons in the p* orbitals give rise to the paramagnetic properties of 
molecular oxygen. The diradical character and accompanying paramagnetism of 
oxygen constitute its outstanding property. 
 
The occupation of antibonding orbitals by one or more electrons cancels 
some of the bonding attraction between the atoms.  In the O2 example, we have 
two p bonding orbitals, each doubly occupied, and a s bonding orbital, doubly 
occupied, or a total of three bonding orbitals.  However, each of the two 
electrons in an antibonding orbital cancel the bonding effect of an electron in a 
bonding orbital, and so the net bonding in oxygen can be considered to result 
from a double bond.  Evidence for the effect of occupation of the antibonding 
orbitals comes from bond distances.  In the ground state, the bond distances 
between oxygen atoms is 1.207 A. (see Table 1)   However, when O2 is ionized 
by loss of an electron from one of the p* antibonding orbitals, the resulting O2+ is 
1.123 A, a considerable decrease, indicative of stronger bonding in the ion.  The 
bond lengths of O2- (a radical anion) and O22- are 1.28 and 1.49 A, respectively, 
confirming the fact that electrons have been added to antibonding orbitals. 
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Table 1.  Electronic and structural properties of oxygen and its derivatives 
 
    Bond order  compounds    O-O     binding energy   n(O-O) 
                         Distance(A)   kcal/mol       cm-1 
 
 O2+    2.5      O2AsF6      1.123a     149.4         1,858c 
O2      2          O2       1.207a     117.2         1,554.7d 
O2(1Dg)   2         O2       1.216e      94.7         1,483.5g 
O2-     1.5         KO2      1.28                    1,145h 
O22-     1          Na2O2    1.49       48.8          842j 
  
aJ. C. Abraham: Quart. Rev. Chem. Soc., 10, 407(1956); bG. Herzberg, “Molecular Spectra 
and Molecular Structure”, 2nd edition. C J. Shamir, J. Beneboym and H. H. Classen, J. Am. 
Chem. Soc., 90, 6223 (1968). dRef. b.  eM. Kasha and A. U. Khan, Ann. N. Y. Acad. Sci., 
171, 5 (1970). fCalculated from the data in footnote d.  gL. Herzberg and G. Herzberg, 
Astrophys. J., 105, 353(1947). hJ. A. Creighton and E. R. Lippencott, J. Chem. Phys., 40, 
1779(1964). i S. N. Foner and R. L. Hudson, J. Chem. Phys., 36, 2676 (1962). jJ. C. Evans, 
J. Chem. Soc., D, 682 (1969). 
 
It is known from chemical studies that O2 can be converted from its 
ground triplet state to a singlet state if energy is supplied, usually in the form of 
light in the presence of a photosensitizer.  Two types of singlet oxygen are 
known (see Table 2) and of these 1O2(1Dg) is more interesting.  Singlet state 1O2 
(1Dg) has a reactivity which is quite different from that of triplet O2; for example, 
1O2 (1Dg) reacts very rapidly with alkenes at room temperature to give allylic 
peroxides or conjugated dienes to give cyclic peroxides. (see below)  
 
 
 
 
 
 
 
 
1,3-Addition(ene-reaction)
H
+
O
O
O
OH
1,4-Addition(Endperoxide formation)
+
O
O
O
O
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Table 2  Electronic configurations of singlet oxygen 
 
       State        p*(2px)     p*(2py)       Energy 
          
       1Sg+                                155 kJ(~13,000 cm-1) 
1Dg                            92 kJ(~8,000 cm-1) 
3Sg-                                 0 (ground state) 
 
 
Oxygen activation in the Oxygenases 
 
Despite its greater reactivity, it is unlikely that singlet O2 is involved in 
very many biological oxygenase reactions.  For one thing, most of the reactions 
catalyzed by oxygenases bear little overall resemblance to known reactions of 
singlet O2; for example most reactions of singlet O2 with organic compounds give 
peroxide products, whereas peroxides are the ultimate products of few oxygenase 
reactions.  Also, singlet O2 does not react with alkanes or unactivated aromatic 
compounds, both of which are frequently substrates for oxygenase reactions.  
However, the most persuasive argument against the involvement of singlet O2 in 
biological reactions is that the lowest energy singlet state (1Dg) is 22 kcal/mole 
higher in energy than the ground state triplet, and it is not apparent how an 
enzyme could supply electronic energy of that magnitude. [4] 
 
In the previous chapter, we have demonstrated that the oxygenation at the 
benzene ring (of phenylalanine or tyrosine) does not occur in the air without the 
catalyst.   
 
 
 
 
 
 
 
 
O2
OH
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Probably the single most important reason for the low kinetic reactivity of 
O2 is that O2 has a triplet ground state---it is a diradical.  On the other hand, the 
stable reduction products (H2O2 an H2O) of O2, and essentially all stable organic 
compounds, including the reactants and products of oxygenase reactions, are 
singlets.  The direct reaction of a triplet molecule with a singlet to give singlet 
products is a spin-forbidden process, i.e., it will not occur readily. In addition to 
this, the reaction of O2 with an organic compound to give a triplet product is 
usually considerably endothermic, and thus cannot occur with most biological 
molecules at physiological temperature. 
 
How do oxygenases cope with the fact that O2 is a triplet and still get it to 
react with organic compounds?  There appear to be two general methods which 
biological systems have evolved to circumvent this problem.  The one method 
by which biological systems circumvent the problem that O2 is a triplet is to have 
the initial reaction of O2 occur by a free radical mechanism.  An example of 
particular relevance to biological chemistry is the reaction fully reduced flavin 
(FH2) with O2.  This reaction has been shown to proceed by a radical mechanism, 
but it only proceeds readily because the intermediate flavin seminquinone radical 
is stabilized by extensive delocalization in the isoalloxazine ring system. 
 
FH2 + O2  →  FH· + HO2·  →  F + H2O2 
 
The other method involves complexing the triplet O2 to a transition metal 
ion which itself has unpaired electrons are more popular in the biological systems.  
The enzymes which catalyze the insertion of oxygen atom(s) of O2 molecule into 
the organic substrates are called “oxygenases”, and many reports have been 
published on the chemical mechanisms of the enzymes (see later chapter).  
However, several important problems remain unsolved on the mechanism of 
oxygenases at present. [10] 
 
Nishida’s Concept on the “Active oxygen species” 
 
Until now, much efforts have been devoted to detection and identification 
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of the so-called “active-oxygen species”, for example a Fe(V)=oxo species, as 
proposed for cytochrome P-450, one of the monooyxgenases (see Figure 6), but 
the Fe(V)=O has not been detected in the reaction cycle of the cytochrome P-450 
as yet. [10] Many biochemists have considered that “active oxygen species” 
generates in the reaction course with the enzyme and oxygen, and then it reacts 
with substrate.  But it should be noted here that there are many reports to 
indicate that enzyme binds oxygen only in the presence of substrate to form the 
ternary complex, ESO2, in which oxygen and substrate interact to give a product.  
However the detail on the interaction between oxygen and the substrate has never 
been discussed. 
    I have pointed out the importance of the electronic interaction between 
oxygen and the substrate in the ternary complex ESO2, and proposed the new 
concept on the oxygen activation, [5-7,9] i.e., the substrate and peripheral 
organic moieties around the metal ion plays an important role in activating 
oxygen, and determining the reaction pathway and the products in the oxygenases, 
and postulated the new mechanism for P-450 as illustrated in Figure 7. [6]  In 
the case of cytochrome P-450CAM, the presence of threonine-252 is very important 
as a peripheral group, as shown in Figure 8.  I also reported that the reactivity of 
the Fe(III)-OOH as an electrophile is similar to that of the Fe(V)=O species in 
terms of the EHMO calculation (see Figure 9: Polyhedron, 13 (1994), 2473), and 
pointed out that the intrinsic active species in the cytochrome P-450 should be a 
Fe(III)-OOH species as shown in Figure 7.   
 
 
 
 
 
 
 
 
 
Figure 6.  Reaction cycle in P-450 proposed by Groves. 
S=substrate 
S-OH=product 
 20
 
 
 
 
 
 
 
 
 
Figure 7.  Reaction cycle in P-450 postulated by Nishida. 
 
 
 
 
 
 
 
 
 
         
 
 
 
Figure 8.  Structure of P-450 in the presence of substrate 
 
In addition to the above, I have observed that in many cases oxygen (O2) 
and hydrogen peroxide ion (O22-) exhibits chemical reactivity similar to that of 
singlet oxygen (1Dg) in the presence of several metal ions such as iron(II), 
iron(III) or copper(II); [5-7] in these cases, the electronic structures of triplet 
oxygen or peroxide molecule is changed through the coordination to a metal 
S=substrate 
S-OH=product 
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ion, and this is greatly promoted by the presence of peripheral organic group 
or substrate. [5-7, 9]   
 
 
 
 
 
 
 
 
 
 
 
Figure 9.  LUMO of Fe(V)=O (right) and Fe(III)-OOH (left) 
          (Polyhedron, 13 (1994), 2473) 
 
These findings are especially important to elucidate the “gain-of-function” 
observed for ALS patients, and also to investigate the chemical mechanism in 
several oxygenases, such as Lipoxygenase, TH, PAH, and tryptophan hydroxylase, 
which will be developed in the subsequent chapters (Chapter V); in the latter 
three cases the participation of pterin to promote the interaction between oxygen 
and Fe(II) ion should be stressed. [9] My original idea on the mechanism of 
oxygenases [5-7, 9] is quite consistent with the recent publications.[11]  
 
Thus I think that the studies to detect, isolate, and identify the so-called 
“active oxygen species” such as Fe(V)=O species proposed in P-450 [10] may be 
interesting on the synthetic chemical point of view, but it is nonsense from the 
biological point of view.  
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Chapter IV. Copper(II)-hydroperoxide Adduct in 
Amyotrophic Lateral Sclerosis (ALS) and Prion 
 Diseases 
 
“Gain-of Function” of Copper(II)-hydroperoxide Adduct 
 
Amyotrophic lateral sclerosis (ALS) is a progressive, devastating 
syndrome that affects both upper and lower motorneurons and results in limb and 
facial motor weakness, atrophy, and death. [1,2]  The age-adjusted world-wide 
incidence of ALS is 0.5-3 per 100,000 person years (without obvious race-related 
differences) Older males and postmenopausal females are most typically related.  
Familial ALS (fALS) accounts for less than 10 % of diagnosed cases, with 
sporadic ALS (sALS) comprising the remainder of diagnoses.  Although the 
pathogenesis of ALS remains unknown, notable progress has been made in 
identifying molecular processes potentially involved in ALS-mediated motor 
neuron injury. 
     A significant discovery in ALS research was the identification of a genetic 
defect associated with 10-15 % of fALS kindreds. The involved gene, SOD1, 
encodes a cytosolic from of superoxide dismutase (SOD), and identified mutations 
in exons, 1,2,4, and 5 of the SOD1 gene all appear to reduce Cu/Zn-SOD stability. 
     Differences in the location of three missence mutations apparently affect 
both clinical fALS severity and measured SOD activity levels.  For example, a 
very short progressive form of fALS in two Japanese kindreds is associated with a 
His46Arg point mutation on the SOD molecule.  This mutation may alter 
Cu2+-binding to the enzymatic catalytic site and reduces erythrocyte lysate SOD 
activity by approximately 20 %.  In Caucasian fALS kindreds with rapid rates of 
clinical disease progression, many SOD1 mutations instead code for the dimer 
contact region and appear to destabilize SOD dimer formation.  Two such point 
mutations (Ala4Val and Gly41Ser) produce an enzyme with less than 5-% of 
normal Cu/Zn SOD activity, and death of affected patients occurs after less than 
one year of symptom onset. 
     To understand ALS pathogenesis, we must understand how altering SOD 
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activity can induce cell injury.  The SOD’s are well-known enzymes that 
catalyze the disproportionation reaction of superoxide ion, [3] which is 
considered to be one of the reaction oxygen species (ROS), into oxygen and 
hydrogen peroxide. 
 
O2- + Cu(II)    →     O2 + Cu(I)                (1) 
      Cu(I) + O2-    →      O2H2 + Cu(II)             (2) 
                      H+ 
 
The crystal structure of the SOD(Cu/Zn) was already determined, [4] 
which is illustrated below (Figure 10).  The copper and zinc ions are bridged by 
anionic form of imidazole ring of His.  
The reaction mechanism of this enzyme has been investigated by many 
authors. Very recently Nishida et al. have postulated new mechanism for this 
enzyme based on the results used by the model compounds.  We have pointed 
out the importance of formation of a copper(II)-OOH species as an intermediate 
(see Scheme-I) in the second step (2) above, and this hydrogen peroxide 
produced is immediately moved from the wild-type enzyme because of the 
negligible interaction between hydrogen peroxide and the copper(II) ion and the 
surrounding organic groups; the former is due to a distorted square pyramidal 
structure of the copper(II) ion in the enzyme, and the hydrogen peroxide is 
destroyed into water and oxygen. 
 
 
 
Scheme-I 
 
 
 
In 1997, Yim et al. have reported that a fALS mutant (Gly93Ala = G93A) 
exhibits an enhanced free radical-generating activity, while its dismutation 
activity is identical to that of the wild-type enzyme. [6]  In Figure 11, ESR 
spectra of DMPO-OH radical adducts formed in solution containing H2O2 and the 
human SOD enzymes.  These are indicating that fALS symptoms are not 
associated with the reduction in the dismutation activity of the enzyme.  They 
Cu(II)
O
O
H
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reported that the mutant and wild-type enzymes contain one copper ion per 
subunit have identical dismutation activities, however, the free-radical generating 
activity of the mutant, as measured by spin-trapping method at low H2O2 
concentration, is enhanced relative to that of the wild-type and G93A, wild-type < 
G93A < A4V.    
 
Figure 10.  Crystal structure of SOD (Cu/Zn) 
 
Figure 11.  ESR spectra of DMPO-OH radical adducts formed in 
solutions containing H2O2 and the human SOD(Cu/Zn).  A; 
wild-type SOD(Cu/Zn), B; G93A mutant SOD, C; A4V mutant SOD, 
D; heat-inactivated SOD (Yim et al., J. Biol. Chem., 1997, 272, 
8861). 
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Siddique et al., have determined the crystal structures of human SOD, along 
with two other SOD structures, and have established that the fALS mutations do 
not change any active-site residues involved in the electrostatic recognition of the 
substrate, the ligation of the metal ions or the formation of the active-site channel, 
but only the slight change in the neighborhood around the copper(II) ion is 
detected.  On the basis of rigorous studies defining the structural and energetic 
effects of conserved hydrophobic packing interactions in proteins, six of the fALS 
mutations would be expected to destabilize the subunit fold or the dimer contact.  
The most frequent fALS mutations would disrupt both, the subunit fold and the 
dimer interface. [7,8] 
 
 
 
 
 
 
 
 
 
             
 
 
  Structure of [Cu(dpgt)]+                                          
 
In order to obtain the comprehensive solution for the correlation between 
the structural change in mutations and pathogenesis of ALS, we have studied the 
reactivity of a copper(II)-OOH, proposed as an important intermediate in the 
SOD reaction.  For this purpose, we have synthesized many copper(II) 
compounds with the ligands which contain N,N-bis(2-picolylmethyl)amine 
moiety, as illustrated in Figure 12. [9] The crystal structure of [Cu(dpgt)Cl]+ is 
illustrated below; the structural features of all other compounds are essentially 
similar to each other, but the slight change was introduced around the copper(II) 
ion. 
 
 27
N
OH
Me
Me
Me
MeH
N
OH
Me
Me
Me
Me
O•
TMPN
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.  Chemical structures of the ligands used in our study 
 
We have measured the ESR spectra of the solution containing a copper(II) 
complex and spin-trapping reagent, such as PBN (a-phenyl-N-t-butylnitrone) and 
TMPN (N,N,N’,N’- tetramethyl-4-piperidinol), specific reagents for OH• radical 
and singlet oxygen (1Dg) (Scheme-II), respectively. [10] 
 
 
 
 
 
 
 
 
            Scheme-II 
 
No ESR signal due to the formation of radical of PBN was detected 
when the copper (II) complex was mixed with H2O2 and PBN.  However, strong 
peaks due to nitron radical formation of the corresponding TMPN (Scheme-II) 
was detected in some cases; especially comparison between the Cu(pipy)Cl+ and 
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N
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the Cu(mopy)Cl+ is interesting.  Structural features of the two compounds are 
essentially the same, instead the difference of the oxygen atom on the morphorin 
ring of Cu(mopy)Cl+ complex is replaced by the –CH2 in the Cu(pipy)Cl+ 
complex. (see the figure below) 
 
 
In the case of Cu(pipy)Cl+, no formation of the nitron radical was observed; on 
contrast to this, high activity for the radical formation by the Cu(mopy)Cl+ 
complex was detected as illustrated in Figure 13.  The similar high activity for 
radical formation of TMPN was also observed for the copper(II) complex with 
H(phpy), [Cu(Hphpy)Cl]+.  In this case, similar to the Cu(mopy)Cl+ complex, 
the addition of the H2O2 to the copper(II) solution does not induce the change in 
ESR spectrum due to the copper(II) ion; but the addition of TMPN leads to the 
dramatic change in the ESR signals attributed to the copper(II) species (i.e., the 
change of hyperfine structure values due to copper atom).  These are all 
comprehensively elucidated on the assumption that the complex formation of 
copper(II), hydrogen peroxide, and TMPN occurs only when three reagents are 
present in the solution, (see the Figure 14), and unique reactivity of the hydrogen 
peroxide observed is detected only when the intermediate is formed in the 
solution.   
  It should be remembered here that in the previous section, we stated 
that --however, the most persuasive argument against the involvement of singlet 
O2 in biological reactions is that the lowest energy singlet state (1Dg) is 22 
kcal/mole higher in energy than the ground state triplet, and it is not apparent how 
 29
an enzyme could supply electronic energy of that magnitude--. Our present 
results clearly show that some copper (II) chelates can activate the hydrogen 
peroxide to exhibit high reactivity similar to that of the singlet oxygen (1Dg). [10] 
 
 
Figure 13.  ESR spectra of the solution containing [Cu(mopy)Cl]+ , 
H2O2, and TMPN.  (a)  measured immediately at the addition of hydrogen 
peroxide, (b) after 5 minutes addition of hydrogen peroxide, (c) after 15 minutes 
addition of hydrogen peroxide 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 14.  Assumed intermediate among copper(II) chelate, 
H2O2 and TMPN. 
(a) 
(b) 
Cu(II)
H
peripheral groupof the ligand system
TMPN
O
O
(c) 
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In order to get further information on the reactivity of a copper 
(II)-OOH species, we have measured the ESI-Mass spectra of the solutions of 
copper (II) compounds and hydrogen peroxide.  When hydrogen peroxide was 
added to the Cu(Me-bdpg)Cl solution (see Figure 12), the formation of 
[Cu(bdpg)Cl], not [Cu(dpal)], was detected by ESI-Mass spectra. [11]  These are 
clearly indicate that Cu(II)-OOH species can cleave the peptide at the C-N bond 
oxidatively, not hydrorytically, because the hydrolytic cleavage may give 
Cu(dpal) species from the Cu(Me-bdpg) compound. 
 
 
 
We also reported that some copper(II) complexes exhibit high activity to 
oxygenate the methionine residue of amyloid beta-peptide(1-40) at sulfur atom 
[12], and decompose the several proteins [13] in the presence of hydrogen 
peroxide.  All these facts may indicate that the “gain-of-function” of the mutant 
SOD is due to formation of a long-lived highly reactive copper(II)-OOH as an 
intermediate in the process of mutant SOD reaction; the chemical structures 
around the copper(II) in the mutant SOD is slightly changed, and this gives an 
unexpected effect on the reactivity of a copper(II)-OOH as observed in our papers.  
In the mutant SOD the C-N bond cleavage by the Cu(II)-OOH may give great 
changes in the surface of SOD, leading to destabilizing of the dimer contact of the 
SOD enzyme. [14] Recent studies have shown that this destabilizing of the dimer 
contact of the SOD enzyme should be a most serious risk factor to induce ALS. 
(O.-Matsumoto and Fridovich, Proc. Natl Acad. Sci. USA., 99(2002), 9010; 
Yamanaka and Cleveland, Neurology, 65(2005), 1859).  
 
It has been generally believed that hydrogen peroxide is relatively inert and 
not toxic to cells, but our experimental facts clearly show that formation and 
Cu
O
C
HN CH3
N O
OH
Cu
O
C NH2
N OH2
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existence of a highly reactive Cu(II)-OOH species is an intrinsic origin for 
oxidative stress in the pathogenesis of ALS, [15] and that the reactivity of the 
Cu(II)-OOH is determined by the structural properties of the intermediate, 
chemical interactions of copper(II)-OOH species with peripheral groups and 
substrate (see Figure 14), [16] and clearly show that OH· radical does not play a 
role in this process. 
 
        Copper(II)-OOH in Sporadic Prion Diseases 
 
PrPC is a glycoprotein expressed on the surface of many cell types and its 
genetic code was identified only after the isolation of an abnormal isoform, PrPSc 
from brains of mice that were infected with the disease scrapie. [17-19]  It is 
generally recognized that PrPC is a copper-containing protein (at most 4 copper 
ions are present within the octarepeat region located in the unstructured 
N-terminus (Figure 2 in page 5)).  Since 1996 there has been increasing evidence 
that PrPC increases cellular resistance to oxidative stress. Cerebelle neurons and 
astrocytes from PrPC knockout mice are more sensitive to superoxide toxicity, 
whereas cells with higher levels of PrPC expression are more resistant to oxidative 
stress. [17]  Analysis of recombinant mouse and chicken PrPC has lead to the 
discovery of an important “gain-of-function” following the formation of the PrPC 
copper complex; PrPC has been shown to contribute directly to cellular SOD 
activity.  Recombinant PrPC that has as least two atoms of copper bound 
specifically has an activity similar to that of superoxide dismutase.   
The copper at the synapse is released in vesicles and studies of copper 
concentration have suggested that the level can reach 250 mM locally. The copper 
released in this way appears to be taken up rapidly by the neurons, and deployed 
within 30 minutes of this process.  It is unknown in what from this copper is 
bound, however it is probable that the copper is chelated to some peptides or 
amino acids because there is little free copper found in the body. [20]  It has 
been pointed out  that the copper(II) chelate compounds which across the 
membrane may originate from the cleavage of the PrPC [17].  Based on the 
results described in the previous section it seems quite likely that these copper(II) 
chelates react with hydrogen peroxide to yield a Cu(II)-OOH species, giving 
serious effects toward the PrPC such as oxygenation at methionine residue, 
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conformational change(i.e., formation of PrPSc), and degradation of protein, if 
hydrogen peroxide is present in the vicinity of synapse (see Scheme-III). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                 Scheme-III 
 
 
As described in Chapter I, the misfolded prions (PrPSc) ultimately kills 
neurons and leaves the brain riddled with holes, like a sponge.  In addition to 
PrPSc, another protease-resistant PrP of 27-30 kDa, which is called as PrP27-30 
was extracted from affected brains. (see the Figure below)   
 
 
 
Cu(II) chelates near the surface of synapse
H2O2
Cleavage, degradation, and conformational change of PrPC
Formation of PrPSc
H2O2
Formation of PrP27-30
Misfolding of the proteins
Formation of aggregates
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It should be noted here that PrP27-30 is derived from only PrPSc (not from 
PrPC), and no difference in amino acid sequence between PrPC and PrPSc have 
been identified. Based on these facts we may assume that the chemical 
environment around the copper ion in the PrPSc should be different from those in 
the PrPC; this situation is similar to the difference observed between the those 
around copper(II) ions in the wild-type and mutant SOD enzyme.  Thus, it is 
most likely that the “gain-of-function” in the PrPSc due to a “highly reactive” 
Cu(II)-OOH formation may occur as described for the mutant SOD molecule, 
which leads to the cleavage of the peptide bonds around the copper ion (near at 
about 90 site), giving PrP27-30 in the presence of hydrogen peroxide. (see 
Scheme III)  
 
       We reported that some copper(II) complexes exhibit high catalytic 
activity to oxygenate the sulfur atom of methionine of amyloid beta-peptide in the 
presence of hydrogen peroxide.[12] Oxidation of methionine residues in the prion 
protein by the hydrogen peroxide attracts recent interests; [24] and it has become 
apparent that Met 129, a residue located in a polymorphic position in human PrP 
and modulating risk of prion diseases, was also easily oxidized as was Met 134.  
The structural effect of H2O2-induced methionine oxidation leads only to a 
modest increase in b-sheet structure. Several experimental facts observed for the 
native prion proteins [21,22,23] seem to be consistent with our results as 
described in the previous section, and the presence, formation, and the serious 
roles of hydrogen peroxide in the biological oxidative stress have been confirmed 
by the present authors. [15,25]  All these findings support our proposal [15] that 
hydrogen peroxide, which derives from the abnormal iron ion metabolism, (see 
Chapter VI) should be the serious origin for the oxidative stress in sporadic 
prion diseases (see Scheme III).   
 
PrPSc formation from PrPC during Infection 
 
PrPSc is extracted from affected brains as highly aggregated, 
detergent-insoluble materials that is not amenable to high-resolution structural 
technique. PrPSc is covalently indistinguishable from PrPC. During infection, the 
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underlying molecular events that lead to the conversion of PrPC to the scrapie 
agent remain ill defined. In vitro experiments have shown that when PrPC was 
taken out of the context of the membranes, it can binds selectively to PrPSc and be 
converted to a protease-resistant state that is indistinguishable from that of PrPSc 
itself.  A schematic model of this two-step process is suggested. [18]  Although 
this PrPSc-induced conversion reaction was originally demonstrated under the 
cell-free conditions containing non-physiological denaturants, it has been adapted 
to much more physiologically compatible conditions.  In fact, in situ conversion 
reactions have been demonstrated using intact, TSE-infected brain slices, 
revealing that both amyloid plaque and diffuse deposits of PrPSc have the ability 
to induce conversion.  The PrPSc-associated converting activity correlates with 
scrapie infectivity in guanidine hydrochloride denaturation studies, and further 
studies based on the protein-protein interaction should be necessary for the 
purposes.  
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Chapter V.  Oxygen Activation in Tyrosine Hydroxylase and its 
 Derivatives:Factors to Prevent the Formation  
of Neurotransmitters 
  
As shown in Chapter II, the mammalian aromatic amino acid 
hydroxylases (phenylalanine, tyrosine, and tryptophan hydroxylases; PAH, TH, 
and TPH, respectively) are a unique class of monooxygenases in their use of 
tetrahydropterins as obligatory cofactors. [1,2]  These enzymes play important 
roles in mammalian metabolism: PAH initiates the detoxifications of high level of 
phenylalanine. Phenylalanine hydroxylase catalyzes the formation of tyrosine; 
mutations in the enzyme are the most common cause of phenylketonuria.  
Tyrosine hydroxylase catalyzes the formation of dihydroxylphenylalanine, the 
first step in the biosynthesis of the catecholamine neurotransmitters, including 
dopamine. Tryptophan hydroxylase catalyzes the formation of 
5’-hydroxytryptophan, the first step in the biosynthesis of the neurotransmitter 
serotonin. These enzymes are monooxygenases, incorporating one atom of 
oxygen from molecular oxygen into the substrate and reducing the other atom to 
water.  The two electrons required for the reduction of the second atom to water 
are supplied by the tetrahydrobiopterin (BH4) substrate.  Phenyalanine 
hydroxylase is present at relatively abundant levels in liver.  Both tyrosine and 
tryptophan hydroxylases are found in the central nervous system.  TH is also 
present in the aderenal gland, a common source of the naturally occurring 
enzyme. 
    In the absence of bound substrates or inhibitors, the active site can be 
identified from the location of the iron atom.  This assignment is supported by 
 37
the results of Maitines, who used the paramagnetic effects of the metals in TH and 
PAH to show that both the aromatic ring of the amino acid substrates ate the 
tetrahydropterin bind closely to the metal.  In both structures the iron is located 
in a hydrophobic cleft 10 A from the surface.  The structure of the iron site in TH 
is shown below. [1,2] There are thee amino acid ligands to the metal, histidine 
331 and 336 and glutamate 376.  In addition, there are two solvent molecules 2.0 
A from the iron, resulting in square pyramidal geometry with histidine 331 as the 
axial ligand.  
 
A direct relationship between the iron content and the activity was 
subsequently established for both PAH and TH enzymes.  The iron is in the 
ferric form when the enzymes are purified.  Reduction of the iron to the ferrous 
state is required for PAH to be active, and metal reconstitution studies have 
shown that TH requires ferrous iron for activity.  Tetrahydroptrins can reduce the 
iron atom in either enzyme, suggesting that BH4 is the physiological reductant.   
        As shown in Figure 4, one of the products of the reactions catalyzed by 
all three hydroxylases is a 4a-hydroxypterin.  The oxygen atoms in both the 
amino acid and the pterin products have been shown to come from molecular 
oxygen.  The formation of this compound establishes that there must be a 
reaction between molecular oxygen and tetrahydropterin during catalysis.  It has 
been accepted that 4a-peroxytetahydropterin is the intermediate results of the 
reaction of the tetrahydropterin and molecular oxygen; Based on the model 
studies with both flavins and pterin, this reaction was assumed to occur in two 
steps; initial slow, single-electron transfer to form superoxide and the pterin 
cation radical followed by rapid combination of the two radicals.  The 
4a-peroxypterin may be considered as a candidate for the hydroxylating 
intermediate, since the analogous 4a-peroxyflavin is thought to be the 
hydroxylating intermediate in the flavin phenol hydroyxlases.  Fitzpatrick et al. 
have proposed [2] that the range of the reaction resembles the reaction catalyzed 
by cytochrome P-450-dependent hydroxylases [3], in which the hydroxylating 
intermediate has been believed to be a high-valence iron-oxo species, and thus it 
seems likely that a more reactive species containing the iron, an iron-oxygen 
species is involved. 
     Dix and Benkovic reported [4] that the amount of hydroxylated amino acid 
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formed agreed well with the amount of 4-hydroxypterin, suggesting that the 
oxygen-oxygen bond is not cleaved unless hydroxylation occurs, and no hydrogen 
peroxide was detected.  Iron is clearly required for activity, and the mutation of 
the ligands to the iron results in the loss of detectable activity.  Electron 
paramagnetic resonance spectrum of enzyme frozen at 7 K during turnover does 
not show any ESR-detectable species, and this can be rationalized by formation of 
the hydroxylating intermediate being much slower than its substitution reaction.  
An additional potential role for the iron atom would be to assist in the reaction of 
tetrahydropterin and molecular oxygen to form the peroxypterin.  The 18O 
kinetic isotope effects determined by Francisco et al. are consistent with either a 
single-electron transfer from tetrahydropterin to oxygen, or with equilibrium 
binding of O2 to the iron atom followed by single-electron transfer from the 
tetrahydropterin to the iron-bound oxygen.  Dix et al have suggested the 
peroxypterin-iron complex as a reasonable intermediate, and pointed out that 
heterolytic cleave of the oxygen-oxygen bond of the species would generate the 
peroxypterin and the iron-oxo hydroxylating species directly. 
     I cannot agree with the opinion that high-valent iron-oxo species is an 
active species in the cytochrome P-450, [5] and since there is no reasonable 
chemical evidences to support the peroxopterin formation proposed by Dix et al., 
we have started the study on the mechanism of these hydroyxlases, and proposed 
quite different mechanism from those published before, and we would like to 
point out that only our mechanism can elucidate the mechanism of the 
hydroxylses reasonably, and give a reasonable explanation for the correlation 
between the neurodegenerative diseases and metal ions. 
 
Nishida’s mechanism for the Hydroxyalses 
 
     In 1991, Mukaiyama et al. have reported that in the presence of a catalytic 
amount of bis(1,3-diketonato)nickel(II) complex, trisubstituted and exo-tetrminal 
olefins or norbornene are smoothly monooxygenated into the corresponding 
epoxides in high to quantitative yields on treatment with aldehyde under an 
atmosphere pressure of oxygen at room temperature.[6] 
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This report have attracted much attention for the chemists, because it is 
generally recognized that the nickel(II) complexes are in generally in the 
oxidation state II, and redox reactions concerning the nickel(II) ion are almost 
rare.  In the previous papers, we already postulated that in some metal 
compounds a transition metal ion such iron(III) or copper(II) can activate oxygen 
without change the oxidation state of the metal ions, [7] which is quite against 
the common sense of general chemists.   
     According to the Nishida’s mechanism, the epoxidation by the Mukaiyama 
reaction can be explained as follows: in the reaction mixture, six-coordinate Ni(II) 
species of acetylacetone, oxygen, and aldehyde, is formed as illustrated in (A) 
below, to give a nickel(II) complex with acylhydroperoxide through the insertion 
of O2 into C-H bond of the aldehyde, and this reacts with olefin to give the 
epoxide and the corresponding acid through the heterolytic cleavage of the O-O 
bond of the acylhydroperoxide (B). [8,9] 
 
 
 
 
 
 
 
 
 
 
 
 
 
In this scheme, the oxidation state of the nickel(II) is unchanged throughout 
the reaction. The formation of the intermediate (A) is promoted through the 
interaction of unpaired electrons in the d-orbital of the nickel (II) ion and that of 
the oxygen molecule (see the Figure 15), and is also promoted through electronic 
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interaction with aldehyde molecule.  In this process, it is anticipated that the 
oxygen coordinated to the nickel(II) is activated to behave as singlet oxygen 
(1Dg), which was confirmed by us experimentally, [8,9] and this will give a 
reasonable explanation for the facile formation of the acylhydroperoxide as 
illustrated in (B) above. 
It should be noted here that the Mukaiyama reaction is very similar to 
those of the hydroxylases, such as TH, i.e., two oxygen atoms of O2 are 
transferred to the substrate and pterin, respectively in TH; the aldehyde used in 
the Mukaiyama reaction is replaced by pterin in TH.  Thus, we may elucidate the 
reaction mechanism of the iron-containing hydroxylases by the use of scheme 
described for the Mukaiyama reaction as shown in Scheme-IV, that is the oxygen 
in the intermediate is activated through interaction with pterin, substrate, and 
d-electron of the Fe(II) ion, to react with the substrate, giving the hydroxylated 
product, which is quite consistent with the observed facts. (Fitzpatrick, J. Mol. 
Biol., 359 (2006), 299.) In the latter process, it is likely that the substrate 
promotes the O-O cleavage, as proposed for cytochrome P-450, etc. [5]  
 
 
 
    
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.  MO scheme for Ni(II)-O2 system.  The formation of orbital 
(b) may be responsible for the appearance of reactivity similar to singlet 
O2 (1Dg). 
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Scheme-IV 
 
 
 
 
 
 
 
 
In our mechanism the weak interaction between the unpaired electrons 
of d-electron and oxygen is very important, and this interaction was already 
confirmed experimentally [10-12].  Thus, when iron ion in the hydroxylase is 
replaced by Al3+, the enzyme cannot give the desired product, because Al3+ ion 
has no unpaired electron.  Generally the interaction between unpaired electrons 
of d-electron and oxygen should be originally weak, but under the special 
conditions, i.e., in the presence of coenzyme such as pterin, etc., this interaction 
occurs, and electronic property of the oxygen in the complex is quite changed 
from that of the stable triplet oxygen in the air.   
In the Mukaiyama reaction, when the Co(acac)2 was used instead of 
nickel(II)-acetylacetonato complex, the Co(II) ion is oxidized to a corresponding 
Co(III) species. [9]  This is because that the activated oxygen in the intermediate 
can oxidize the Co(II) ion, and the resulted Co(III) is greatly stabilized; in the 
case of nickel(II) compound the oxidation to a Ni(III) is impossible because the 
Ni(III) state is very unstable in the air, but the best yields of the products are 
obtained in the case of Ni(II) complex used.  The change of the oxidation state 
of the metal ion is not suitable for this oxygenation reaction 
 
 
Difference between Fe(II) and Mn(II) ions in Oxidation Reaction 
 
The a-keto acid-dependent enzymes are distinguished from other non-heme 
iron enzymes by requirement of an a-keto acid cofactor as well as Fe(II) and O2 
for reactivity. (see Figure 16) [13]  They now constitute a large class of enzymes 
which are essential in the biosynthesis of many biological compounds.   
 
Examples of these enzymes are illustrated below: In general, the reactions 
Fe(II)
O2
pterin
substrate
substrate:phenylalanine,
               tyrosine
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catalyzed by these enzymes involve the oxidation of an unactivated C-H bond to 
give either hydroxylated products.  In these systems, a-keto acid may behave as 
pterin in TH, and the aldehyde in Mukaiyama reaction, respectively. 
 
 
 
 
 
 
 
      
 
 
 
 
 
  Figure 16.  Examples of a-keto acid-dependent dioxygenases. [13] 
 
In general, these enzymes require 1 equiv of Fe(II), and a-keto acid (usually 
a-ketoglutarate), and ascorbate for full activity.  Substitution with other divalent 
metal ions (Zn(II), Mn(II), Co(II), Mg(II), and Ni(II)) results in the complete loss 
of enzymatic activity [13]  These facts are clearly show that the oxidation 
activity by the Fe(II) ion is completely different from those of other metal ions, 
especially Mn(II). This should be due to that Mn(II) compounds are in favour of 
the “two-electron oxidation” reaction and readily oxidized to an Mn(IV) ion, 
whereas “one-electron reaction”, for the Fe(II) species. This is clearly 
exemplified in our recent results., i.e., Mn(II) ion of the complex Mn(ntb)ClClOl4, 
which is very stable in air, is readily oxidized to a Mn(IV) ion in the presence of 
reducing agent, cycloyhexane-carboxyaldehyde in air; the mechanism of the 
Mn(IV) formation is written below. [14]   
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These are indicating that in the biological iron-containing hydroxylases, 
the replacement of the iron ion by a Mn(II) ion will give rise to great loss of the 
enzymatic activity.  It should be remembered here that the recent investigations 
of scrapie, CJD, and CWD clusters in Iceland, Slovakia, and Colorado have 
indicated the soil in these regions is low in copper and higher in manganese as 
described in Chapter I. Brown et al. have reported that prion protein loses the 
SOD-like activity when Cu is replaced with Mn in recombinant PrP, and also that 
Cu binding to PrP purified from sporadic CJD was significantly decreased while 
the binding of Mn and Zn was markedly increased. It should be quite likely that 
the Mn(II) ions in the prion protein may degrade the surrounding peptide bonds in 
the presence of aliphatic aldehyde, such as 4-hydroxy-2-nonenal, frequently 
observed for the iron-overload patients, (Zainal et al., Free Radical Biology 
Medicine, 26(1999), 1181) and in the presence of hydrogen peroxide, because 
under these conditions formation of a Mn(IV) species is facile and these Mn(IV) 
species is highly reactive towards proteins and DNA, etc. 
 
“Manganism” and its origin  
 
As a nutrient, manganese is an essential component of several enzymes; a 
deficiency can lead to heart and bone problems and in children, stunted growth.  
However, it has been known since 1837 that workers in manganese mines can 
develop manganism, [17] a dreaded illness marked by Parkinson’s-like tremors, 
violent outbursts, and hallucinations. Victims have lesions in the globus pallidus 
and striatum of the basal ganglia, a part of the brain involved in fine muscle 
control.  When manganese (this should be manganese oxide) is inhaled, blood 
ferries it from the lungs to the brain, where it can readily cross the blood-brain 
barrier.  As stated before, excess manganese ions in the brain should lead to 
the deficiency of neurotransmitters, and this should give the most reasonable 
explanation for the “manganism” observed.  Several studies have demonstrated 
that iron deficiency increases transport of orally administered manganese into the 
body as well as delivery to the brain. (Aschner et al. Ann. NY Acad Sci. 
1012(2004), 115; Gunter et al., NeuroToxicology, 27(2006), 765; Erickson and 
Aschner, NeuroToxicology, 27(2006), 125; Heilig et al., Am. J. Physiol. Cell Mol 
Physiol., 290(2006), L1247) 
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Many countries in the world completed phasing out leaded gasoline 
(gasoline containing tetraethyl-lead), paving the way for widespread use of a 
manganese-based compound, MMT, in gasoline. (MMT=methyl cyclopentadienyl 
manganese tricarbonyl)  The additive increases octane level, which boosts 
engine performance and enables fuel to be burned more evenly.  This means 
that manganese oxide, one of the famous chemical carcinogens, is widely 
spread in the sky, and the human inhale the manganese oxide every day, which is 
stored in the lung.  The use of MMT should be stopped as soon as possible! 
 
Al3+ ion in Neurodegenerative Diseases 
 
As described above, it is clear that an unpaired d-electron plays an 
important role in activating O2 in the iron-containing enzymes.  If the Fe(II) is 
replaced by an another metal with no unpaired d-electrons such as Al3+ ion, it is 
quite likely that such enzymes cannot activate O2, thus giving rise the deficiency 
of the neurotransmitters.  In order to get more information on this problem, we 
have compared the reactivity of the Al(III) compounds with those of the 
corresponding Fe(III) compounds.  We have prepared several binuclear iron(III) 
complexes with H(HPTB) and H(HPTP) shown below, and determined the crystal 
structure of Fe2(HPTP)Cl4ClO4, which is illustrated below. (H(HPTP) 
=N,N,N’,N’-tetra(2-pyridylmethyl)- 1,3-diaminopropanol)). 
 
 
 
 
 
 
 
 
 
 
 
Structure of Fe2(HPTP)Cl4 cation. 
 
We have found these two binuclear iron(III) complexes give high positive 
TBARS in the reaction with linolenic acid in the air [18,19]; here TBARS are 
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malondialdehyde (which gives pink products with TBA; lmax=532 nm) or 
monoaldehyde derivatives (gives orange products), which are formed from the 
peroxidation of linolenic acid. (TBA= 2-thiobarbituric acid; see Figure 17). [20] 
Above results have been elucidated on the assumption that oxygenation of 
O2 into the linoleic acid proceeds without the change of oxidation state of Fe(III) 
through forming an intermediate containing two iron(III) ions, O2, and linoleic 
acid, as illustrated in Scheme-V; this is very similar to that proposed for the 
elucidation of Mukaiyama reaction and lipoxygenase.  In this case, the 
interaction between the two unpaired electrons of two iron(III) atoms and O2 
( ······ in Scheme-V, see below) is necessary to activate the O2, which is also 
promoted via interaction with the substrate, linolenic acid.   
 
 
 
 
Scheme-V 
 
 
 
 
 
              
Figure 17.  Absorption 
spectra of   the 
reaction mixtures 
treated with TBA 
according to the usual 
procedures. [18,19]  
A: Fe2(HPTP)Cl4ClO4 
and linolenic   acid,  
B: Al2(HPTP)(OH)Cl2 
(ClO4)2 and linolenic acid 
 
 
 
 
The binuclear Al(III) complex, Al2(HPTP)(OH)Cl2(ClO4)2 was also isolated.  
The activities for the oxygenation of linolenic acid by these two binuclear Fe(III) 
and Al(III) compounds were compared by measuring the quantities of the TBARS 
compounds, and the results are shown in Figure 17.  This clearly shows that 
 FeIII
FeIII
O
O
substrate
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Al(III) complex exhibit no activity for the oxygenation of linoleic acid (the 
absorbance at 532 nm is much lower than that due to the corresponding iron(III) 
complex), and this can be attributed to the absence of unpaired d-electron in 
Al(III) complex, and this also supports the importance of role of unpaired 
d-electron in the activation of O2.   
The similar fact was also observed when the DMPO, which is one 
of the famous spin-trapping agent for OH• radical, was added to the solution 
containing binuclear iron(III) complex, Fe2(HPTP)(OH) (NO3)22+;strong four 
signals which correspond to the formation of DMPO-OH have appeared as 
illustrated in Fig. 18, [21]  whereas no such signal was detected by the 
addition of DMPO to the solutions of Fe(edta)- and Al2(HPTP)(OH)Cl2(ClO4)2.  
This clearly indicates that the formation of DMPO-OH is not due to the 
presence of OH• in the solution.  Above mysterious fact was elucidated by the 
similar way as described for the oxygenation of linolenic acid through the 
formation of the intermediate similar to that assumed for the linolenic acid 
(Scheme-V), O2 is activated to interact with the DMPO, leading to DMPO-OH 
formation.  These demonstrate that the results obtained by the use of 
spin-trapping reagents, especially for the formation of OH• by DMPO, are 
doubtful, and the results reported hitherto should be re-investigated, and thus I 
cannot support the discussion on the presence of so-called Fenton reaction in 
the biological systems. 
 
Figure 18.  ESR spectra of the solutions added by DMPO. [21] 
        
A: Fe2(HPTP)(OH)(NO3)22+ (upper)        B: Fe(edta)Na (lower) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) 
(B) 
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As shown in the previous Chapter, ALS and Parkinson’s and Alzheimer’s 
patients were collectively found in the New Gunia and Papua island, and its origin 
has been postulated to be the drinking subterranean water, which contains much 
concentrations of Al3+ and Mn2+, and increased aluminum and manganese levels 
were reported in the hippocampus and the motor cortex patients with Alzheimer’s 
disease [15 ] and in the brain of CJD patients [16], respectively Thus, it seems 
likely that the elevated concentration of these Al3+ and Mn2+ is a one of the 
serious origins of these endemic sporadic neurodegerative diseases, and this 
should be closely related with the fact the replacement of the iron ion by another 
metal ion leads to the loss of activity of the enzymes which play a central role in 
the synthesis of neurotransmitters. 
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Chapter VI  Non-specific Iron ion and Abnormalities 
      in Brain Iron Metabolism 
 
Human iron metabolism and absorption has been the subject of a recent 
review.  Normal human males contain 3-5 g of iron (often less in females) and of 
this, two-thirds is in circulating red cells as hemoglobin and 15-25 % in storage in 
ferritin and hemosiderin. [1]  The remaining iron is in muscle myoglobin (about 
8 %) and in cytochromes and iron-containing enzymes.  Plasma transferrin 
accounts for only 3 mg of Fe, but the daily exchange if iron through plasma 
transferrin is ten times this account.  Transferrin therefore plays a central role in 
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iron distribution.  Iron delivery by transferrin to etythroid and many 
non-erythroid cells involves interaction of transferrin with specific receptors 
followed by endocyosis and recycling of apotransferrin and receptor.  These 
receptors are present in low amounts on phagocytosis cells which receive their 
iron from degraded red cell hemoglobin.  In the case of hepatocytes it has been 
proposed that iron is released by reduction at the plasma membrane rather than 
receptor-mediated endocytosis, but there is no evidence for a diferric reductase in 
rat liver plasma membrane.  Under pathological conditions (e.g., iron overload 
syndrome) the amount of iron not bound to transferrin may become important 
(these are called non-specific iron ions).  This is distributed to organs in an 
inappropriate manner leading to iron overload in parenchymal organs such as 
liver and pancreas.   
     Genetic (idiopathic or hereditary) haematochromatosis is one of the most 
common genetic disorder in western populations, particularly among Celtic 
peoples.  This disease is associated with greatly increased (sometimes 50-fold) 
deposits of storage iron, predominantly as haemosiderin, in the liver and other 
tissues due to abnormally high absorption from the gut, although there seems to 
be little or no ferritin in the duodenal absorption cells.  The excess iron cannot 
be eliminated and must be stored.  Elevated body iron leads to increased iron in 
storage (and not to increases in hemoglobin, myoglobin, etc. except in the 
treatment of iron deficiency anaemia)  Under normal iron loading, ferritinis the 
major storage form, but in diseases of iron overload, the capacity to synthesize 
ferritin levels off and haemosiderin becomes predominant.   
Normal cells store iron mainly in ferritin molecules, but under conditions 
of iron overload some of it is shunted into another source of storage form known 
as haemosiderin.  Several data support the hypothesis that haemosiderin is a 
degradation product of ferritin, and this has been confirmed for phytosiderin, an 
insoluble iron-containing product from pea seed, which was found to contain a 
peptide derived from the ferritin subunit.  These findings indicated that ferritin is 
taken up by lysosomes, and that subsequent processing involved a partial 
dissolution of the core, and degradation to siderosomal ferritin and to the 
insoluble haemosiderin.  Thus the haemosiderin from various iron-loaded 
animals were consistently found to have ferrihydrite-like iron cores similar to 
ferritin, and haemosiderin is typically insoluble, as isolated, in contrast to the 
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soluble ferritin, but it can be solubilized by treatment with alkali and detergents, 
and also with the several amino acids or small peptides, so-called non-specific 
iron, which exist in brain as soluble dimeric (or polymeric) compounds, similar 
to Fe2(HPTP)Cl4+, or with (nta); the latter complex is of a m-oxo bridged dimeric 
structure, [Fe2O(nta)2(CO3)]2-, as illustrated below. [2,3]  It should be noted here 
that these binuclear iron(III) compounds give rise to increased oxidation of lipids, 
proteins, DNA damages, and also cell death in the presence of hydrogen peroxide. 
[3-6] 
 
 
 
 
 
 
 
 
 
 
 
 
Hydrogen Peroxide Formation by binuclear iron(III) Species: 
            A renal carcinogen, Fe(III)-(nta) Complex 
 
It is noteworthy that the oxidation of the TMPD, one of the famous 
one-electron donor, is greatly accelerated in the presence of the binuclear iron(III) 
complex, Fe2(HPTP)Cl4+ or binuclear copper(II) complex, [7,8] to give much 
quantity of hydrogen peroxide (see the following equation); this indicates that the 
soluble dimeric iron(III) species can produce hydrogen peroxide in the presence 
of reducing agent and O2.   
 
FeIII2(HPTP)Cl4+ + 2TMPD + O2  →  FeIII2(HPTP)Cl4+ + 2TMPD+ + O22-   
 
In the biological systems, there are many enzymes that operate as reductase, 
such as glutathione reductase, etc.  If the dimeric iron(III) chelates approaches to 
this enzyme under an aerobic condition, the reductase may give hydrogen 
peroxide, and thus it is quite reasonable to assume that oxidative degradation of 
the proteins and sugars may occur in the vicinity of this enzyme in the .presence 
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of the iron carcinogen, Fe-nta via formation of binuclear iron(III)-peroxide adduct 
(see below), and this should be due to fact that the carbonato ion in the original 
binuclear iron(III)-(nta) complex is easily released from the compound. ([4] and 
Nishida et al., Chem. Lett., 1994, 641; Synth. Reac. Inorg. Metal-org. Nano-Metal 
Chem., 36(2006), 373).  
 
 
 
 
 
 
 
  
 
This may give a reasonable explanation to the facts observed by Okada et 
al., they reported that redox-active iron caused free radical injuries in the 
proximal tubes of mice kidneys after injection of a renal carcinogen Fe(III)-(nta) 
and induced the apoptosis of the proximal tubular epithelial cells. But, this injury 
was not observed in the distal portion, and at this proximal portion glutathione 
reductases are operating. (Okada et al., Arch. Biochem. Biophys., 301(1993), 138; 
Kawabata et al., Carcinogenesis, 18(1997), 1389; Kafel et al., Chemosphere, 
65(2006), 963). 
 
 In the previous chapter, we have shown that hydrogen peroxide should be 
an intrinsic factor to induce the pathogenesis of sporadic scrapie and BSE as 
illustrated in Scheme-III in Chapter IV.  Very recently we have reported that the 
capillary electrophoresis method (CE) is very suitable to investigate the 
conformation change of the proteins and aggregation states of the proteins in 
solution. [Nishida, Annu. Report CIN, 2004, 1; Nishida et al., Synth. Reac. Inorg. 
Metal-org. NanoMetal Chem., 35(2005), 379; Nishida et al., Synth. Reac. Inorg. 
Metal-org. NanoMetal Chem., 35(2005), 677;  Chem. Lett., 34(2005), 141; 
Nishida et al., Z. Naturforsch., 62c(2006), 273]  As an example, two CE profiles 
of SOD and transferrin are illustrated in Figure 19.  Although the concentrations 
of the two solutions are the same, the peak intensities are quite different from 
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O
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FeIII FeIII(nta)
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O O
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each other, and this has been rationalized on the fact that SOD has a rigid dimeric 
structure in solution, but that of apo-transferrin is more flexible.  In fact, at least 
three components are observed in the CE of holo-transferrin.  We also have 
found that the presence of excess hydrogen peroxide (and also some non-specific 
iron observed that species such as [Fe2(HPTP)Cl4]+, etc) induces the loosening or 
dissociation of dimeric structure of SOD molecule (see Figure 20), [9] which has 
been considered to be one of the main origins of ALS (see Chapter IV).  Thus, it 
seems quite likely that sporadic ALS is related with the excess hydrogen peroxide 
(and also some non-specific iron species and copper(II) chelates [9,10]) in brain, 
and the similar discussion may be applied to the elucidation of sporadic prion 
diseases as described before. (see Chapter IV). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Figure 19. CE profiles of the solutions (protein 0.5mg/1ml).  A:  SOD 
B and C (after 60 min.), Apo-transferrin. (Chem. Lett., 34(2005), 
141) 
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Figure 20. CE profiles of the solutions (protein 0.5 mg/1ml) 
containing SOD.A: SOD only.  B hydrogen peroxide solution 
was added to Solution A, (0 min.) and C, after 60 min. [9] 
 
 
Abnormal Iron Metabolism due to Increased Al3+ and  
Mn2+ Ions in brain 
 
 
As shown in Chapter I, increased aluminum levels were reported in the 
hippocampus of patients with Alzheimer’s disease and specific regions such as 
the hippocampus and the motor cortex contain elevated iron levels.  In contrast 
to iron levels, ferritin levels were differentially altered in the brain of patients 
with Alzheimer’s disease.  This suggests that iron overload syndrome may be 
induced through the accumulation of exogenous metal ions such as Al3+ and 
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Mn2+; as stated above, the accumulation of Al(III) and Mn(II) ions in brain will 
lead to the deficiency of dopamine and other neurotransmitters, and under this 
circumstances the brain will order the transferrin to transport the iron ion to the 
enzyme, but the transported metal ions including Fe(III) and Al(III) should be 
discarded to the tissue, because the enzyme is loaded with the metal ion, Al(III), 
etc.; this is consistent with the many facts observed. [11,12] 
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Chapter VII  Summary 
 
We have investigated the chemical mechanism of pathogenesis of 
sporadic prion diseases based on the new concept on “oxidative stress” induced 
by the metal ions; our conclusion is summarized as follows: 
 
1) In iron-containing enzymes, tyrosine-, phenylalanine-, and 
tryptophan-hydroxylase, Fe(II) ion activates O2 through weak 
interaction between the unpaired electrons of Fe(II) ion and O2, which 
is promoted by pterin, giving rise to hydroxylated benzene ring.   
Other metal ions such as Al(III) or Mn(II) cannot activate O2 by the 
similar ways, leading to the deficiency of neurotransmitters, and to the 
elevated iron levels in brains.  Elevated iron levels in brains and 
abnormalities in brain iron metabolism have been detected for 
Alzheimer’s and Parkinson’s diseases, and these iron ions serve to the 
formation of the so-called non-specific iron ions, and  
2) The so-called non-specific iron ions, generally soluble polynuclear 
Fe(III) species, exhibit unique reactivity toward O2, and gives 
hydrogen peroxide in the presence of reducing agents.  The hydrogen 
peroxide thus produced readily forms a metal-OOH, 
hydroperoxo-metal chelates of Fe(III) or Cu(II) chelates. These 
metal-OOH species are highly reactive to oxidation of cellular 
constituents, such as proteins, and DNA, which lead to DNA damages, 
mutant proteins, misfolded proteins, and protein aggregations.  Thus 
the formation of “highly reactive” copper(II)-OOH species in vivo is 
closely related with the initial step of pathogenesis of sporadic ALS 
and prion diseases. 
 
Based on these results, we would like to propose that the most important risk 
factor to induce sporadic prion diseases is the abnormal accumulation of Al(III) or 
Mn(II) ions in brain, which leads to the abnormalities in brain iron metabolism 
(formation of non-specific iron ions), and in fact the cell-death due to 
“iron-overload syndrome” was already reported by several authors.  Thus, the 
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sudden and explosive increase of scrapie and BSE in the last decade in Europe 
may be partially due to “acid rain”, because the acid rain makes Al(III) and 
Mn(II) ions soluble in the subterranean aquifers.  
 
 In the 21st century we must do many works to prevent the increases 
of Al3+ and Mn2+ ions in brain in our dairy life, and make adequate 
countermeasures for “acid rain”.  Strong acid rain dissolves out the iron ions 
from the surface of the mountains and hills, leading to iron-deficiency in many 
trees, which should be a critical origin for the abnormal autumn tints frequently 
observed in recent Japan.  I already proposed new methods to maintain the 
healthy forests and woods in Japan, which should be the best way towards the 
acid rain, and to maintain the healthy brain in human lives, leading to 
decrease or prevention of metal diseases such as depression, and violent or 
rough children, etc. 
 
